Immunai
AI-powered immune system mapping platform that supports biopharma companies in drug discovery and development decisions.
Informations sur l’outil
Qu'est-ce que Immunai ?
Immunai is an AI-powered platform that maps the immune system at high resolution with multiomic data and AI-driven insights. It helps biopharmaceutical companies make informed decisions across target discovery, preclinical evaluation, and clinical trial optimization by transforming therapeutic questions into actionable recommendations.
Fonctionnalités principales
Target Discovery
Discover and validate novel molecular targets that matter most in human disease using patient-derived single-cell data and functional genomics to ensure causal involvement in the disease process.
Preclinical Evaluation
Strengthen confidence in preclinical safety and efficacy by identifying features linked to favorable pharmacodynamic characteristics, molecular mechanisms for patient stratification, and translational strategies connecting preclinical findings to clinical success.
Clinical Trial Optimization
Optimize clinical trial design by identifying patient subgroups likely to respond or tolerate treatment, building data-driven rationale for indications, doses, or combinations, and better understanding drug mechanism of action compared to standard of care.
End-to-end Platform Workflow
Transforms therapeutic questions into actionable recommendations through five steps: Generate high-quality multiomic single-cell data, Augment with AMICA immune database, Compute novel immune features via machine learning, Validate with functional genomics, and Recommend clear paths forward.
AMICA Database
The world’s largest immune-focused, harmonized single-cell database used to enrich generated data and enhance analytical power for deeper immune insights.
Cas d'utilisation
- #1
Novel Therapeutic Target Identification
Identify and validate high-impact molecular targets linked to disease using unbiased, data-driven recommendations and experimental evidence to shorten the path from hypothesis to actionable target.
- #2
Preclinical Candidate Prioritization
Prioritize promising drug candidates by assessing safety, efficacy, and translational potential to ensure successful progression into the clinic.
- #3
Clinical Development Strategy Optimization
Support smarter clinical trial design, patient stratification, dose/combination selection, and mechanism of action understanding to maximize trial success and bring better therapies to patients.
- #4
Biopharma Partnership Collaborations
Partner with biopharmaceutical companies and research institutions on projects such as IBD target discovery and vitiligo disease mechanism and biomarker discovery.
Alternatives
Foire aux questions
What is Immunai?
How does Immunai’s platform workflow work?
What is the AMICA database?
Who is Immunai designed for?
What pricing information is available for Immunai?
Immunai Contacts et réseaux sociaux
- Adresse430 E 29th St, New York, NY 10016, USA
- E-mail d'assistance
- Assistance
- Site Internet :
- Twitter
- YouTube
- LinkedIn
Avis
Partagez votre expérience avec cet outil...